CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 99 enrolled
Drug / intervention
Honeywell HomMed Telemonitordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01393314
NCT01393314N/ACompleted
CompareCT.gov

A Randomized Controlled Trial of Telemonitoring in Older Adults With Heart Failure

Case Western Reserve University·interventional·Posted Jul 13, 2011·Updated Aug 10, 2022

In Brief

A clinical study evaluating Honeywell HomMed Telemonitor for Heart Failure. Completed, enrolled 99 participants.

Detailed Summary

This is a randomized controlled trial of telemonitoring vs usual care provided by home care agencies for patients with heart failure. The study hypothesis is that Telemonitoring will reduce hospital re-admission rates, urgent care visits, unscheduled physician appointments, Emergency Room visits in patients with heart failure over the 60 day post hospitalization period.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 13, 2011
Enrollment StartNov 1, 2007
Primary CompletionMar 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 15.0 years ago

Interventions

Honeywell HomMed Telemonitordevice

telemonitoring post hospitalization